LCM
DTIL icon

Lynx1 Capital Management’s Precision BioSciences DTIL Stock Holding History

Lynx1 Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.47M Sell
950,466
-34,647
-4% -$244K 0.86% 8
2026
Q1 		$5.42M Sell
985,113
-8,800
-0.9% -$40.6K 0.86% 10
2025
Q4 		$4.13M Sell
993,913
-48,683
-5% -$276K 0.84% 11
2025
Q3 		$5.76M Buy
1,042,596
+6,545
+0.6% +$31.3K 1.17% 8
2025
Q2 		$4.35M Buy
1,036,051
+270,000
+35% +$1.33M 1.26% 9
2025
Q1 		$3.65M Hold
766,051
– – 1.31% 9
2024
Q4 		$2.92M Buy
+766,051
New +$5.59M 1.09% 12

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lynx1 Capital Management's DTIL Position: Q2 2026 in Review

Lynx1 Capital Management reduced its Precision BioSciences (DTIL) stake by 3.5% in Q2 2026, selling an estimated $244K and leaving 950,466 shares worth $7.47M. The position accounts for 0.86% of the portfolio, ranked #8.

Lynx1 Capital Management first reported a position in DTIL in Q4 2024 and has held it in 7 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Lynx1 Capital Management held 950,466 shares of Precision BioSciences worth $7.47M as of Q2 2026.
  • Lynx1 Capital Management sold 34,647 Precision BioSciences shares in Q2 2026, an estimated $244K.
  • Precision BioSciences made up 0.86% of Lynx1 Capital Management's portfolio in Q2 2026, its #8 holding.
  • Lynx1 Capital Management first reported a position in Precision BioSciences in Q4 2024 and has held it in 7 quarters since.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Lynx1 Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.